1-3 of 3
Moshe Ornstein, MD, MA
Close
Sort by
Journal Articles

Impact of a Cancer Associated Thrombosis Clinic on Reducing Hospitalization for Venous Thromboembolism: The Cleveland Clinic Experience

Amber Afzal, MD, Alok A. Khorana, MD, Moshe Ornstein, MD MA, Keith McCrae
Journal: Blood
Blood (2015) 126 (23): 5588.
https://doi.org/10.1182/blood.V126.23.5588.5588
Published: 2015
Journal Articles

Predictive Factors for Latency Period and a Prognostic Model for Survival in Patients with Therapy-Related AML.

Moshe Ornstein, MD, MA, Sudipto Mukherjee, MD PhD, Sanjay R. Mohan, MD, Paul Elson, ScD, Ramon V. Tiu, MD, Yogenthiran Saunthararajah, M.D., Leslie Farhat, Cassandra Kendeigh, Anjali Advani, MD, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS
Journal: Blood
Blood (2012) 120 (21): 2589.
https://doi.org/10.1182/blood.V120.21.2589.2589
Published: 2012
Journal Articles

Vancomycin-Resistant Enterococcus (VRE) Bacteremia During Acute Myeloid Leukemia (AML) Induction Therapy Is an Independent Predictor of Poor Outcome

Moshe Ornstein, MD, MA, Sudipto Mukherjee, MD PhD, Michael K. Keng, MD, Paul Elson, ScD, Ramon V. Tiu, MD, Yogenthiran Saunthararajah, MD, Leslie Farhat, Diane Banks, Anjali Advani, MD, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS
Journal: Blood
Blood (2012) 120 (21): 1487.
https://doi.org/10.1182/blood.V120.21.1487.1487
Published: 2012